Search results
What Makes Ligand (LGND) a New Strong Buy Stock
Zacks via Yahoo Finance· 1 day agoYou can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>>. Earnings Estimate Revisions for Ligand This drugmaker is expected...
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 5 days agoEli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a...
Wu-Tang Clan's single-print album to play at Australian museum
Reuters· 2 days agoU.S. hip-hop group Wu-Tang Clan's one-of-a-kind album "Once Upon A Time in Shaolin" will be played...
A Life Expansion Revolution Is Coming: 3 Stocks That Could Lead the Charge
Motley Fool via Yahoo Finance· 3 days agoLilly's 2019 partnership with Atomwise, an AI-driven drug discovery company, started the company...
Wegovy's Precarious Position: 3 Drugs Most Likely to Dethrone Novo Nordisk's Blockbuster Obesity...
Motley Fool via Yahoo Finance· 1 day agoNovo Nordisk's CagriSema Even with Zepbound/Mounjaro breathing down Wegovy's neck, there's good news...
Here is What to Know Beyond Why Novo Nordisk A/S (NVO) is a Trending Stock
Zacks via Yahoo Finance· 5 days agoNordisk (NVO) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good...
Want to Get Richer? 2 Top Stocks to Buy Now and Hold Forever.
Motley Fool via Yahoo Finance· 2 days agoEli Lilly's recently approved drug can potentially help prescribed users shed excess pounds and...
Another potential indication for Mounjaro, Zepbound
Becker’s Hospital Review· 4 days agoTirzepatide, the main ingredient for Eli Lilly's Mounjaro and Zepbound, omitted the presence of metabolic dysfunction-associated steatohepatitis in a phase 2 study, the drugmaker< ...
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 3 days agoAbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want...
Bidding war erupts for D.C.’s Vanda Pharmaceuticals - Washington Business Journal
The Business Journals· 2 days agoA bidding war has erupted for D.C.’s Vanda Pharmaceuticals Inc. (NASDAQ: VNDA). The local drugmaker...
